Evidence map›Paper›PMID 26130389›Full record

ReviewMolecular systems biology2015

Modeling cancer metabolism on a genome scale.

Keren Yizhak, Barbara Chaneton, Eyal Gottlieb, Eytan Ruppin

Open access · goldAbstract readReview
In one paragraph

Review in Molecular systems biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 189 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The return of metabolism: biochemistry and physiology of glycolysis.Biological reviews of the Cambridge Philosophical Society · 2026
    Review
  6. Dynamic metabolic modelling of ATP allocation during viral infection.Journal of the Royal Society, Interface · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Genome-scale knockout simulation and clustering analysis of drug-resistant breast cancer cells reveal drug sensitization targets.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Genome-scale models in human metabologenomics.Nature reviews. Genetics · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Keren YizhakThe Blavatnik School of Computer Science, Tel Aviv University, Tel Aviv, Israel kerenyiz@post.tau.ac.il ruppin@post.tau.ac.il.
Barbara ChanetonCancer Research UK, Beatson Institute, Glasgow, UK.
Eyal GottliebCancer Research UK, Beatson Institute, Glasgow, UK.
Eytan RuppinThe Blavatnik School of Computer Science, Tel Aviv University, Tel Aviv, Israel The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD, USA kerenyiz@post.tau.ac.il ruppin@post.tau.ac.il.
Cancer Research UK Scotland Institute · GBTel Aviv University · IL

Funding

Cancer Research UK 18278
6 · The paper itself

Abstract

Cancer cells have fundamentally altered cellular metabolism that is associated with their tumorigenicity and malignancy. In addition to the widely studied Warburg effect, several new key metabolic alterations in cancer have been established over the last decade, leading to the recognition that altered tumor metabolism is one of the hallmarks of cancer. Deciphering the full scope and functional implications of the dysregulated metabolism in cancer requires both the advancement of a variety of omics measurements and the advancement of computational approaches for the analysis and contextualization of the accumulated data. Encouragingly, while the metabolic network is highly interconnected and complex, it is at the same time probably the best characterized cellular network. Following, this review discusses the challenges that genome-scale modeling of cancer metabolism has been facing. We survey several recent studies demonstrating the first strides that have been done, testifying to the value of this approach in portraying a network-level view of the cancer metabolism and in identifying novel drug targets and biomarkers. Finally, we outline a few new steps that may further advance this field.

Indexed as

Systems BiologyHumansMetabolic Networks and PathwaysModels, BiologicalNeoplasmsCancer metabolismGenome‐scale simulationsMetabolic modeling

Identifiers

PMID26130389
PMCPMC4501850
OpenAlexW2099291727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.